Total investments received (USD): 9.48m
Round value (USD): 5.27m
Round investors:
Calculus Capital
Par Equity UK
Company: Axol Bioscience



Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain